Pendal Group Ltd - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 70 filers reported holding AUTOLUS THERAPEUTICS PLC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 1.0%.

Quarter-by-quarter ownership
Pendal Group Ltd ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q4 2022$3,293,443
+12.3%
1,733,391
+26.5%
0.03%
-3.4%
Q3 2022$2,933,000
-24.1%
1,370,757
+0.4%
0.03%
-23.7%
Q2 2022$3,864,000
-32.6%
1,365,429
-0.7%
0.04%
-19.1%
Q1 2022$5,734,000
-23.5%
1,375,106
-4.8%
0.05%
-21.7%
Q4 2021$7,499,000
-18.7%
1,444,802
+2.6%
0.06%
-21.1%
Q3 2021$9,225,000
+100.5%
1,408,317
+164.1%
0.08%
+81.0%
Q2 2021$4,602,000
+338.7%
533,250
+338.7%
0.04%
+320.0%
Q1 2021$1,049,000
+133.1%
121,565
+141.4%
0.01%
+100.0%
Q4 2020$450,00050,3540.01%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q4 2022
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 2,283,966$15,166,0001.40%
Sio Capital Management, LLC 591,870$3,930,0000.98%
TFG Asset Management GP Ltd 2,500,000$16,600,0000.90%
Ikarian Capital, LLC 1,356,048$9,004,0000.73%
SABBY MANAGEMENT, LLC 400,050$2,656,0000.37%
Nantahala Capital Management 1,793,500$11,909,0000.34%
Regency Capital Management Inc.\DE 57,000$378,0000.29%
Eversept Partners, LP 473,074$3,141,2110.21%
MYDA Advisors LLC 85,000$564,0000.14%
Henry James International Management Inc. 54,047$359,0000.10%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders